Zydus’ Usnoflast receives US FDA orphan drug designation to treat ...
1 天前 · Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 …
Lilly's Omvoh receives US FDA approval to treat Crohn's disease in …
2025年1月17日 · Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that …
Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle …
Industry demands targeted reforms to drive pharma industry …
4 天之前 · As India’s pharmaceutical and healthcare industries brace for the Union Budget 2025, key stakeholders highlight the need for targeted reforms to drive pharma industry growth, …
Six start-ups bestowed with new ‘heart of pharma’ at Pharmapack …
1 天前 · Pharmapack Europe 2025 taking place from January 22 to 23, has selected six start-ups from its 26 strong field of innovators to receive the Pharmapack Europe ‘heart of pharma’. A …
AstraZeneca’s anti-complement medical therapy, eculizumab …
2025年1月17日 · AstraZeneca Pharma India received a Central Drugs Standard Control Organisation (CDSCO) permission to import, sale or distribute ‘Eculizumab’ concentrate …
US FDA accepts and grants priority review status to Dizal’s ...
2025年1月9日 · Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the US Food and Drug …
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Pfizer’s Hympavzi receives US FDA approval to treat adults and ...
2024年10月14日 · Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST]